Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemoglobinopathies at 54th American Society of Hematology (ASH) Annual Meeting
Yahoo/BusinessWire
Saturday, December 8, 2012 - 11:18am
tags:
Alnylam, β-thalassemia
Invest in the Great Progress of Hepatitis C
Motley Fool
Saturday, December 8, 2012 - 11:17am
tags:
hepatitis C, Gilead Sciences, sofosbuvir, Medivir, TMC435, ACH-1625, Achillion
Pharmacyclics Blood-Cancer Drug Controls Disease in Study
Bloomberg
Saturday, December 8, 2012 - 11:06am
tags:
chronic lymphocytic leukemia, ibrutinib, Pharmacyclics
Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
Seeking Alpha
Saturday, December 8, 2012 - 11:04am
tags:
Gilead Sciences, hepatitis C, sofosbuvir
SAC Capital’s InterMune Trades Said to Be Probed by FBI
Bloomberg
Saturday, December 8, 2012 - 11:03am
tags:
InterMune
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, December 8, 2012 - 11:02am
tags:
Geron, Amarin, Acadia
Analyst Debate: Is Arena Pharmaceuticals a Top Stock?
Motley Fool
Saturday, December 8, 2012 - 11:01am
tags:
Arena Pharmaceuticals, Belviq, weight loss, obesity
Pain Therapeutics Declares Special One-Time Cash Distribution to Shareholders
Yahoo/GlobeNewsWire
Saturday, December 8, 2012 - 11:00am
tags:
Pain Therapeutics
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, December 8, 2012 - 11:00am
tags:
Hi-Tech Pharmacal, Aetna, Dendreon
Galena Presents Data, Sarepta Updates Study: Healthcare Business Wrap
Wall Street Cheat Street
Saturday, December 8, 2012 - 10:57am
tags:
Sarepta Therapeutics, Galena Biopharma, Abiomed, CombiMatrix
How AstraZeneca Has Fared During 2012
Motley Fool
Friday, December 7, 2012 - 12:02pm
tags:
AstraZeneca
7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Friday, December 7, 2012 - 11:45am
tags:
Alexza, BiogenIdec, Celsion, Celgene, Sanofi, JNJ, Threshold Pharmaceuticals
Another Unbelievable Month for Sarepta
Motley Fool
Friday, December 7, 2012 - 11:44am
tags:
Sarepta
Pfizer markets $ billion revolving credit to back spinoff
Reuters
Friday, December 7, 2012 - 11:43am
tags:
Pfizer, animal health, Zoetis
The Revolution of The Pharma Industry
Motley Fool
Friday, December 7, 2012 - 11:42am
tags:
patent cliff
3 Biopharmaceuticals Weighed By Uncertainty
Seeking Alpha
Friday, December 7, 2012 - 10:56am
tags:
Vivus, Orexigen, obesity, Arena Pharmaceuticals
Sequenom shares climb after company receives patent protecting process behind test
Yahoo/AP
Friday, December 7, 2012 - 10:56am
tags:
Sequenom, patents, Maternit21 Plus
Amarin's Stock Drops on Plan to Sell Heart Drug Vascepa Alone
Minyanville
Friday, December 7, 2012 - 10:51am
tags:
Vascepa, Amarin
The Price May Be Increasing For An Amarin Buyout
Seeking Alpha
Friday, December 7, 2012 - 10:50am
tags:
M&A, Vascepa, Amarin
BioCryst To Trim 50% Of Its Workforce
NASDAQ.com
Friday, December 7, 2012 - 10:45am
tags:
Biocryst, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.